Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial

DiscussionPROTID is anticipated to generate key evidence to guide decisions over the use of TB preventive treatment among people with DM as an important target group for better global TB control.Trial registrationClinicalTrials.govNCT04600167. Registered on 23 October 2020
Source: Trials - Category: Research Source Type: clinical trials